Our research group has previously demonstrated that CA 19-9 levels can rise independently from CEA in about 15% of cases, and we have specifically observed this increase in grade 3 colorectal adenocarcinoma [29]. This evidence concerns the gene CEACAM5 and colorectal adenocarcinoma.